Companies

SBC Medical Group Holdings Inc

SBC, SBCWW · CIK 0001930313 · operating

$0.31+3.91%Last updated Mar 2, 4:47 PM

Key Statistics

Valuation

Market Cap
P/E
Fwd P/E
PEG
P/S
P/B0.13
EV/EBITDA
EV/Rev

Profitability

Gross Margin75.97%
Op. Margin34.23%
Net Margin22.69%
ROE23.89%
ROA17.52%
FCF Margin8.77%

Financial Health

Current Ratio3.01
Debt/Equity0.36
Free Cash Flow$18.02M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta1.14
52W High$0.309
52W Low$0.309

About SBC Medical Group Holdings Inc

# SBC Medical Group Holdings Inc

SBC Medical Group Holdings operates a network of cosmetic treatment centers under the SBC brand across Japan, Vietnam, the United States, and Singapore. The company provides both surgical and non-surgical cosmetic procedures, including breast augmentation, liposuction, rhinoplasty, laser treatments, hair transplants, and various rejuvenation procedures addressing wrinkles, acne, scars, and signs of aging.

Beyond direct patient care, the company generates revenue through a franchise model and comprehensive support services for franchisee clinics. These services include staff recruitment and training, facility design and construction, IT software solutions, booking and reservation systems, and employee housing assistance. The company also operates as a distributor of medical consumables, equipment, implants, injection materials, and beauty products to its clinic network for resale to patients.

Additional revenue streams include advertising and marketing services across social media platforms, management consulting, and program support functions. Founded in 2000 and headquartered in Irvine, California, the company operates with approximately 863 full-time employees. Its geographic diversification across Asia-Pacific markets and North America reflects a multi-regional business strategy centered on the cosmetic treatment sector.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$0.48$0.48
2023
2022

Annual Reports (10-K) · 3 filings

Report DateFiledAccession Number
2024-12-312025-03-280001641172-25-001062SEC ↗
2023-12-312024-03-190001493152-24-010402SEC ↗
2022-12-312023-03-090001493152-23-007036SEC ↗